| pubmed-article:1418176 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1418176 | lifeskim:mentions | umls-concept:C0014544 | lld:lifeskim |
| pubmed-article:1418176 | lifeskim:mentions | umls-concept:C0231335 | lld:lifeskim |
| pubmed-article:1418176 | lifeskim:mentions | umls-concept:C0048044 | lld:lifeskim |
| pubmed-article:1418176 | lifeskim:mentions | umls-concept:C0035363 | lld:lifeskim |
| pubmed-article:1418176 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
| pubmed-article:1418176 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:1418176 | pubmed:dateCreated | 1992-12-23 | lld:pubmed |
| pubmed-article:1418176 | pubmed:abstractText | The effects of vigabatrin were studied over a 6-month period in 43 patients with intractable epilepsy. Children with complex partial seizures, with or without secondary generalization, responded best with more than one-half achieving a greater than 50% reduction; generalized tonic-clonic seizures also improved but there was no significant change in absence or myoclonic seizures. Four patients are seizure-free on monotherapy with vigabatrin. The drug was well tolerated with few side effects. | lld:pubmed |
| pubmed-article:1418176 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1418176 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1418176 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1418176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1418176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1418176 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1418176 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1418176 | pubmed:issn | 0887-8994 | lld:pubmed |
| pubmed-article:1418176 | pubmed:author | pubmed-author:GibbsJ MJM | lld:pubmed |
| pubmed-article:1418176 | pubmed:author | pubmed-author:RosenbloomLL | lld:pubmed |
| pubmed-article:1418176 | pubmed:author | pubmed-author:AppletonR ERE | lld:pubmed |
| pubmed-article:1418176 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1418176 | pubmed:volume | 8 | lld:pubmed |
| pubmed-article:1418176 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1418176 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1418176 | pubmed:pagination | 338-40 | lld:pubmed |
| pubmed-article:1418176 | pubmed:dateRevised | 2006-5-23 | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:meshHeading | pubmed-meshheading:1418176-... | lld:pubmed |
| pubmed-article:1418176 | pubmed:articleTitle | Vigabatrin in intractable childhood epilepsy: a retrospective study. | lld:pubmed |
| pubmed-article:1418176 | pubmed:affiliation | Department of Neurology, Royal Liverpool Children's Hospital, Alder Hey, England. | lld:pubmed |
| pubmed-article:1418176 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1418176 | lld:pubmed |
